Early Rheumatoid Arthritis Check

Detects the presence of antibodies against citrullinated peptides, which are proteins formed due to amino acid modifications through citrullination. These antibodies are strongly associated with rheumatoid arthritis and are considered an important marker for early diagnosis of the disease, even before clear clinical symptoms appear.

• Individuals experiencing symptoms of arthritis, such as joint pain, swelling, or stiffness.
• People with a family history of rheumatoid arthritis.
• Patients presenting with nonspecific immune-related symptoms, such as fatigue and chronic tiredness.
• Individuals showing signs of inflammation, such as fever or skin rash.
• Patients whose condition requires further evaluation to confirm rheumatoid arthritis diagnosis or differentiate it from similar diseases.

• Joint pain and swelling, especially in small joints such as hands and wrists.
• Joint stiffness, particularly in the morning or after periods of inactivity.
• Severe fatigue or general tiredness.
• Mild fever or general discomfort.
• Skin rashes or inflammatory-related skin changes.
• Family history of rheumatoid arthritis or other autoimmune diseases.

• Negative (Normal) Result Indicates absence or low levels of antibodies, usually less than 20 units per milliliter (U/mL).
• Positive Result Values are usually above 20 U/mL, which may indicate the presence of rheumatoid arthritis or a higher risk of developing it.